Fresenius SE Total Current Assets 2016-2024 | FSNUY
Fresenius SE total current assets from 2016 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
- Fresenius SE total current assets for the quarter ending June 30, 2024 were $12.861B, a 38.9% decline year-over-year.
- Fresenius SE total current assets for 2023 were $13.55B, a 29.64% decline from 2022.
- Fresenius SE total current assets for 2022 were $19.259B, a 6.77% decline from 2021.
- Fresenius SE total current assets for 2021 were $20.658B, a 14.66% increase from 2020.
Fresenius SE Annual Total Current Assets
(Millions of US $) |
| 2023 |
$13,550 |
| 2022 |
$19,259 |
| 2021 |
$20,658 |
| 2020 |
$18,016 |
| 2019 |
$17,096 |
| 2018 |
$17,467 |
| 2017 |
$14,246 |
| 2016 |
$13,057 |
| 2015 |
$12,122 |
Fresenius SE Quarterly Total Current Assets
(Millions of US $) |
| 2024-06-30 |
$12,861 |
| 2024-03-31 |
$12,311 |
| 2023-12-31 |
$13,550 |
| 2023-09-30 |
$48,798 |
| 2023-06-30 |
$21,050 |
| 2023-03-31 |
$20,504 |
| 2022-12-31 |
$19,259 |
| 2022-09-30 |
$19,583 |
| 2022-06-30 |
$20,026 |
| 2022-03-31 |
$20,202 |
| 2021-12-31 |
$20,658 |
| 2021-09-30 |
$20,440 |
| 2021-06-30 |
$20,364 |
| 2021-03-31 |
$20,125 |
| 2020-12-31 |
$18,016 |
| 2020-09-30 |
$19,678 |
| 2020-06-30 |
$18,887 |
| 2020-03-31 |
$18,027 |
| 2019-12-31 |
$17,096 |
| 2019-09-30 |
$16,880 |
| 2019-06-30 |
$16,693 |
| 2019-03-31 |
$16,989 |
| 2018-12-31 |
$17,467 |
| 2018-09-30 |
$16,967 |
| 2018-06-30 |
$17,039 |
| 2018-03-31 |
$16,482 |
| 2017-12-31 |
$14,246 |
| 2017-09-30 |
$15,126 |
| 2017-06-30 |
$14,078 |
| 2017-03-31 |
$13,936 |
| 2016-12-31 |
$13,057 |
| 2016-09-30 |
$12,322 |
| 2016-06-30 |
$12,426 |
| 2016-03-31 |
$11,676 |
| 2015-12-31 |
$12,122 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$19.704B |
$24.011B |
|
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|
